EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Gabapentin CNS exposure and analgesic response are modulated by OCT2 genotype in patients with chronic neuropathic pain

Lina Zhou, Priscila A Yamamoto, Melody Walker, Ana Carolina Conchon Costa, Gabriela R Lauretti, Fabiola Dach, Stephan Schmidt, Natalia Valadares de Moraes

Frontiers in Pharmacology · 12.03.2026 · 17

DOI: 10.3389/fphar.2026.1760901 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 12.03.2026. Verfasst von Lina Zhou und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Pharmacometrics and Systems Pharmacology, College of Pharmacy, University of Florida, Orlando, FL, United States. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Gabapentin (GBP) is commonly used for chronic neuropathic pain, yet its therapeutic response varies widely across individuals. As a substrate of the organic cation transporter 2 (OCT2), encoded by the SLC22A2 gene, GBP’s penetration into the central nervous system (CNS) may be influenced by genetic variability. This study aimed to characterize the impact of SLC22A2 c.808G>T polymorphism on GBP pharmacokinetics (PK) and pharmacodynamics (PD) and inform genotype-guided dosing strategies.

Methods

Data from two clinical studies (n = 94) were pooled, including single and multiple oral dose regimens of GBP. Population PK/PD modeling was performed using nonlinear mixed-effects modeling.

Results

A two-compartment PK model with first-order absorption and linear elimination best described GBP disposition, with estimated apparent clearance (CL/F) significantly influenced by renal function (eGFR). Pain scores revealed delayed pain relief relative to peak plasma levels, requiring an effect compartment to link PK to an Imax model. The SLC22A2 c.808G>T (OCT2) variant was associated with a 10-fold reduction in the influx rate constant (ke 1 ) to the effect site, suggesting impaired CNS drug delivery. Simulations demonstrated that GT carriers experienced markedly reduced pain relief, even at the maximum approved doses, compared to GG homozygotes. Renal impairment increased systemic exposure but did not alter CNS penetration.

Conclusion

These findings highlight the importance of the OCT2 genotype in modulating GBP’s analgesic efficacy. Incorporating transporter pharmacogenetics into PK/PD models may enhance individualized therapy for neuropathic pain, particularly in identifying poor responders who may benefit from alternative dosing or adjunct treatments.

Schlagwörter

Stichwörter der Autor:innen

OCT2gabapentinneuropathic painpharmacogeneticspopulation PK/PD modeling

Autor:innen und Institutionen

  • Center for Pharmacometrics and Systems Pharmacology, College of Pharmacy, University of Florida, Orlando, FL, United States.
  • School of Medicine of Ribeirao Preto, University of Sao Paulo, Ribeirao Preto, Sao Paulo, Brazil.

Zitieren

APA

Zhou, L., Yamamoto, P. A., Walker, M., Conchon Costa, A. C., Lauretti, G. R., Dach, F., Schmidt, S., & de Moraes, N. V. (2026). Gabapentin CNS exposure and analgesic response are modulated by OCT2 genotype in patients with chronic neuropathic pain. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1760901

Vancouver

Zhou L, Yamamoto PA, Walker M, Conchon Costa AC, Lauretti GR, Dach F, et al. Gabapentin CNS exposure and analgesic response are modulated by OCT2 genotype in patients with chronic neuropathic pain. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1760901

BibTeX
@article{Zhou2026,
  author = {Zhou, Lina and Yamamoto, Priscila A and Walker, Melody and Conchon Costa, Ana Carolina and Lauretti, Gabriela R and Dach, Fabiola and Schmidt, Stephan and de Moraes, Natalia Valadares},
  title = {Gabapentin CNS exposure and analgesic response are modulated by OCT2 genotype in patients with chronic neuropathic pain},
  journal = {Frontiers in Pharmacology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fphar.2026.1760901}
}
Kostenlos starten →